Service Corporation International (SCI) Investor presentation summary
Event summary combining transcript, slides, and related documents.
Investor presentation summary
13 Jan, 2026Strategic priorities and business model
Focus on growing revenue, leveraging scale, and deploying capital to drive long-term value.
Financial flexibility supported by $1.54B in liquidity and a leverage ratio within the 3.5x–4.0x target range.
Largest player in a fragmented deathcare market, holding a 16% revenue share in the U.S. and Canada.
Competitive advantages include national brand, leading technologies, supply chain efficiencies, and integrated funeral-cemetery locations.
Financial performance and shareholder returns
$7.4B returned to shareholders via dividends and share repurchases since 2004, with a 57% reduction in outstanding shares.
Dividends per share have grown at a 16% CAGR from 2005 to 2024, reaching $1.40 per share.
Superior total shareholder returns: 3-year annualized return of 11%, 5-year of 16%, and 10-year of 16% as of September 2024.
Adjusted EPS guidance for 2024 is $3.47–$3.57, establishing a new base for future growth.
Growth framework and outlook
Long-term earnings growth framework targets 8–12% organic growth, with 5–7% from funeral and mid-single-digit growth from cemetery preneed sales.
Capital deployment of 3–5% supports reinvestment, acquisitions, and share repurchases.
Four key growth pillars: demographic tailwinds, enhanced marketing and sales, cemetery inventory opportunities, and preneed backlog.
2024 guidance: adjusted operating cash flow of $950M and maintenance capital expenditures of $325M.
Latest events from Service Corporation International
- Urban network, pre-need backlog, and tech-driven efficiency fuel growth and future outlook.SCI
47th Annual Raymond James Institutional Investor Conference3 Mar 2026 - Adjusted EPS rose 8% in Q4 and 9% for the year, with 2026 guidance targeting further growth.SCI
Q4 202513 Feb 2026 - Earnings growth, robust M&A, and tech-driven efficiency position the business for strong future gains.SCI
Raymond James & Associates’ 46th Annual Institutional Investors Conference 20253 Feb 2026 - Normalized growth, margin expansion, and evolving cremation trends shape the outlook.SCI
BofA Securities Leveraged Finance Conference 20253 Feb 2026 - Q2 revenue up, adjusted EPS down; strong cash flow and capital returns; guidance at lower end.SCI
Q2 20242 Feb 2026 - Q3 2024 delivered stable profits, strong cash flow, and record acquisitions for future growth.SCI
Q3 202417 Jan 2026 - Stabilized volumes, moderated cremation shifts, and strong pre-need sales drive 2026 growth.SCI
UBS Global Healthcare Conference 202513 Jan 2026 - Strong market position, robust cash flow, and strategic growth drive superior shareholder returns.SCI
Investor presentation13 Jan 2026 - Industry leader with strong cash flow, superior returns, and 2025 EPS growth aligned with targets.SCI
Investor presentation13 Jan 2026